Oct 20, 2025 · Tezspire (tezepelumab-ekko) is used in adults and adolescents 12 years and older for the maintenance treatment of severe asthma in those whose asthma is not controlled with …

TEZSPIRE is an add-on medication to treat patients 12 and older with severe asthma and adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Learn more about TEZSPIRE …

TEZSPIRE® (tezepelumab-ekko), add-on maintenance treatment for severe asthma and CRSwNP, is the first and only biologic approved to target TSLP and help address epithelial-driven …

Aug 1, 2024 · Find patient medical information for Tezspire (tezepelumab-ekko) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Tezepelumab is indicated for the add-on maintenance treatment of people aged twelve years and older with severe asthma. [6][8] The most common side effects include arthralgia (joint pain) …

Dec 1, 2025 · Tezepelumab-ekko injection is used together with other medicines as maintenance treatment for severe asthma. Tezepelumab-ekko helps prevent severe asthma attacks …

Dec 17, 2021 · TEZSPIRE™ (tezepelumab-ekko) U.S. Indication TEZSPIRE is a first-in-class medicine indicated for the add-on maintenance treatment of adult and pediatric patients aged …

Oct 17, 2025 · 1.1 Asthma - TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma. Limitations of Use: …

Medscape - Severe asthma dosing for Tezspire (tezepelumab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …

Jun 6, 2024 · Learn about Tezspire (tezepelumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.